Qiagen NV (NYSE: QGEN) has a higher price-to-earnings ratio of 26.66x compared to its average ratio. QGEN has 36-month beta value of 0.43. Analysts have mixed views on the stock, with 3 analysts rating it as a “buy,” 0 as “overweight,” 7 as “hold,” and 0 as “sell.”
The public float for QGEN is 220.30M, and currently, short sellers hold a 1.34% ratio of that float. The average trading volume of QGEN on April 25, 2024 was 1.02M shares.
QGEN) stock’s latest price update
Qiagen NV (NYSE: QGEN)’s stock price has plunge by -2.02relation to previous closing price of 41.52. Nevertheless, the company has seen a 3.07% surge in its stock price over the last five trading sessions. Zacks Investment Research reported 2024-04-24 that Evaluate the expected performance of Qiagen (QGEN) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
QGEN’s Market Performance
Qiagen NV (QGEN) has experienced a 3.07% rise in stock performance for the past week, with a -4.73% drop in the past month, and a -7.70% drop in the past quarter. The volatility ratio for the week is 1.43%, and the volatility levels for the past 30 days are at 1.47% for QGEN. The simple moving average for the last 20 days is -1.14% for QGEN stock, with a simple moving average of -4.12% for the last 200 days.
Analysts’ Opinion of QGEN
Many brokerage firms have already submitted their reports for QGEN stocks, with Wells Fargo repeating the rating for QGEN by listing it as a “Equal Weight.” The predicted price for QGEN in the upcoming period, according to Wells Fargo is $44 based on the research report published on December 19, 2023 of the previous year 2023.
Goldman gave a rating of “Buy” to QGEN, setting the target price at $50 in the report published on December 07th of the previous year.
QGEN Trading at -4.60% from the 50-Day Moving Average
After a stumble in the market that brought QGEN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -14.71% of loss for the given period.
Volatility was left at 1.47%, however, over the last 30 days, the volatility rate increased by 1.43%, as shares sank -4.84% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -5.09% lower at present.
During the last 5 trading sessions, QGEN rose by +3.07%, which changed the moving average for the period of 200-days by -9.98% in comparison to the 20-day moving average, which settled at $41.04. In addition, Qiagen NV saw -6.32% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for QGEN
Current profitability levels for the company are sitting at:
- 0.24 for the present operating margin
- 0.64 for the gross margin
The net margin for Qiagen NV stands at 0.17. The total capital return value is set at 0.09. Equity return is now at value 9.38, with 5.50 for asset returns.
Based on Qiagen NV (QGEN), the company’s capital structure generated 0.29 points at debt to capital in total, while cash flow to debt ratio is standing at 0.3. The debt to equity ratio resting at 0.4. The interest coverage ratio of the stock is 8.73.
Currently, EBITDA for the company is 650.58 million with net debt to EBITDA at 1.32. When we switch over and look at the enterprise to sales, we see a ratio of 5.06. The receivables turnover for the company is 3.81for trailing twelve months and the total asset turnover is 0.32. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.99.
Conclusion
To put it simply, Qiagen NV (QGEN) has had a bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
